Search Results 741-750 of 16277 for pharmacogenetics
Your Mayo Clinic care team ... Mayo Clinic's MGUS teams are led by specialists in blood disorders, known as hematologists. The team includes other specialists as ...
Mayo Clinic experts research and test new treatments for focal segmental glomerulosclerosis (FSGS) through the Mayo Nephrology Collaborative Group. As a Mayo ...
Mayo Clinic Radio: Memory test scoring for Alzheimer's disease / adult cochlear implants / optimism · Mayo Clinic researchers look at post menopause as key ...
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...
The Knowledge Synthesis Program in the Mayo Clinic Kern Center for the Science of Health Care Delivery identifies and examines knowledge to apply the best ...
About this study. The purposes of this study are to evaluate whether pre-NAC peripheral blood immune phenotypes (defined by mass cytometry) are associated ...
The purpose of this study is to evaluate whether encorafenib plus cetuximab (EC), alone or in combination with chemotherapy, can improve clinical outcomes ...
Patients with Acute Myeloid Leukemia (AML) in complete remission will receive eltrombopag while undergoing consolidation chemotherapy with high-dose cytarabine.
The purpose of the study is to evaluate the safety of Rifaximin or placebo in subjects with severe hepatic impairment and Hepatic Encephalopathy. Participation ...
c. Cancer Biology and Translational Research: John A. Copland III · Cardiovascular Tissue Engineering Research: Leigh G. Griffiths · Cell and Molecular ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.